Acute Immune Thrombocytopenia (ITP) Following COVID-19 Vaccination in a Patient With Previously Stable ITP
- PMID: 34307734
- PMCID: PMC8294682
- DOI: 10.1093/ofid/ofab343
Acute Immune Thrombocytopenia (ITP) Following COVID-19 Vaccination in a Patient With Previously Stable ITP
Abstract
Immune thrombocytopenia (ITP) is an autoimmune condition associated with multiple risk factors including viral infections (hepatitis B virus/hepatitis C virus/cytomegalovirus, HIV, and recently severe acute respiratory syndrome coronavirus 2) and vaccines. Though immune mechanisms have been proposed to explain the pathogenesis of acute ITP, autoimmunity with the coronavirus disease 2019 (COVID-19) vaccine is still unclear and needs further research. We report a case of acute ITP after administration of the Pfizer-BioNTech mRNA COVID-19 vaccine in a patient with previously stable ITP.
Keywords: COVID-19; Pfizer; SARS-CoV-2; immune thrombocytopenic purpura; vaccination.
© The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Figures
References
-
- COVID-19 vaccine tracker. New York State. Available at:https://covid19vaccine.health.ny.gov/covid-19-vaccine-tracker. Accessed 02/20/21.
-
- The Vaccine Adverse Event Reporting System (VAERS) request. Centers for Disease Control and Prevention (CDC). Available at: https://wonder.cdc.gov/vaers.html. Accessed 02/20/21.
-
- Justiz Vaillant AA, Gupta N.. ITP-Immune Thrombocytopenic Purpura. Treasure Island, FL: StatPearls Publishing; 2020. - PubMed
-
- Rodeghiero F, Stasi R, Gernsheimer T, et al. . Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 2009; 113:2386–93. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
